| Market Cap | ₹42,112Cr |
| ROE | 55.94% |
| P/E Ratio(TTM) | 44.08 |
| EPS(TTM) | 56.39 |
| P/B Ratio | 24.66 |
| Dividend Yield | 2.17% |
| Industry P/E | 32.15 |
| Book Value | 100.80 |
| Debt to Equity | 0.02 |
| Face Value | 10 |
| Managing Director | Bhushan Akshikar |
| Founded | 1924 |
| NSE Symbol | GLAXO |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Abbott India | NA (0.00%) | 38.55 | ||
| Astrazeneca Pharma India | NA (0.00%) | 107.73 | ||
| Pfizer | NA (0.00%) | 25.04 | ||
| Sanofi Consumer Healthcare India | NA (0.00%) | 45.02 |